MAP BioPharma is a U.K. based life science consultancy that works with several partners who share their vision to accelerate patient access and support Pharmaceutical and MedTech companies in reaching patients sooner with their medicines, devices, and diagnostics. Christian Hill, CEO & Co-Founder of MAP BioPharma says that “BioPortUSA facilitates entry for overseas-life sciences companies into the United States so are a natural fit and addition to MAP’s network and we look forward to working with them to support our clients”.
MAP BioPharm’s extensive knowledge of the European healthcare environment provides strategic guidance for successful European Market entry. Operating in a diverse market requires careful consideration. Their team will guide you through the necessary steps and provide a blueprint to ensure that you have covered all the requirements for the European Market.
Christian has built a solid company, with an incredible network that will no doubt benefit our clients who are looking to go overseas. We in turn look forward to supporting MAPBioPharma clients who are looking to gain entry into the USA’’ says CEO & Founder Mark Lesselroth.